Reactivation of mutant p53 has been shown previously in xenograft models under ‘chemotherapeutic settings' where tumors are formed before the systemic administration of the drugs.29, 30 In this study, the inhibitory effect of PEITC was demonstrated under conditions that mimic cancer ‘chemopreventive settings'. Here, TP53 is linked to cancer.